Scarce Resources are best Applied to Prevention The Anti Argument
|
|
- Lilian Douglas
- 5 years ago
- Views:
Transcription
1 Scarce Resources are best Applied to Prevention The Anti Argument Lawrence N Shulman, MD Director, Center for Global Cancer Medicine Abramson Cancer Center, University of Pennsylvania Senior Oncology Advisor Partners In Health
2 Cancer Treatment in Resource-Constrained Settings? Too expensive, too complex can t be done in resourceconstrained settings you will kill more people than you will help Giving out free cancer drugs would not help the poorest parts of Africa, the head of a pharmaceutical giant has told the BBC. He said "dramatic" progress was being made in treating tumours, and defended the company's pricing policy. And he said that training doctors, not the cost of drugs, was the biggest issue in the world's poorest countries. Access to treatment has been one of the key themes of the world's biggest cancer conference You should focus completely on prevention which is less costly and more feasible and 1/3 of cancers are preventable (real quotes)
3 Prevention versus Treatment A false argument. It is not an either or As was shown with HIV/AIDS prevention and treatment strategies strengthen each other.
4 Do we turn our backs on these children with a potential 80% cure rate? None have preventable cancers.
5 If you want to have the biggest impact on reducing cancer-related mortality world-wide.you need to bring the tools we currently have at our disposal to the many cancer patients who have no access.. But it those tools must be used effectively and safely
6 What is the vision for global cancer care? Patients should expect accessible, high-quality cancer care for treatable and preventable cancers Care should be affordable poverty should not be a barrier to care for many in the world this will mean care must be free Efforts should aim to develop and strengthen incountry capacity for all aspects of cancer care and for the full spectrum of cancer specialists
7 The Continuum of Cancer Care and Services Education Risk Reduction Screening Diagnostics Early Detection Treatment Survivorship Palliative Care
8 Cancers where we could make an impact (not all-inclusive list): Diseases amenable to risk reduction Tobacco control lung, head and neck, bladder HPV vaccine Cervical and H&N Hepatitis vaccine - Hepatocellular Diseases curable with early detection, surgery, and treatment Breast cancer, Cervical cancer, Sarcoma, Colon cancer Diseases curable with affordable chemotherapy Non-Hodgkin s Lymphoma (Burkitt s/large cell) Hodgkin s Lymphoma Testicular cancer Acute Lymphoblastic Leukemia in children Diseases palliated with systemic treatment Chronic Myeloid Leukemia Advanced Breast cancer Kaposi s sarcoma
9 Principles of Cancer Care at PIH Sites Treatment program without on-site oncologists or hematologists but with the back-up of specialists via electronic communication weekly calls between the Dana-Farber Cancer Institute and Rwanda teams There will not be enough oncologists to care for most of the world s cancer patients for decades, and so we need alternate models Now supported by ASCO
10 Journal of Clinical Oncology 2015
11 Benefits of Implementation Science First and foremost improve care for the benefit of our cancer patients Prove to international organizations, governments, and NGOs that safe and effective cancer care is possible in these settings Prove to funders that it is worth supporting cancer care
12 How do we get from this
13 Fabrice, 4 years old Dx Wilms Tumor Inexpensive chemotherapy And Surgery Disease-free Estimated cost - $1,400 USD
14 Journal of Global Oncology 2016
15 59% of children disease-free Journal of Global Oncology 2016
16 Chronic Myeloid Leukemia Imatinib Free from the Max Foundation
17 Journal of Global Oncology 2016
18 95% of patients alive, and 75% in hematologic remission Journal of Global Oncology 2016
19 Linking humility and bold vision to scientific rigor is the surest route to value and equity in global health. Dr. Agnes Binagwaho, Former Minister of Health, Rwanda
World Health Organization: Essential Medicines and Devices for Cancer:
World Health Organization: Essential Medicines and Devices for Cancer: Principles, Methodologies, and Outcomes Lawrence N. Shulman, MD Abramson Cancer Center, University of Pennsylvania Partners In Health
More informationImpact of Pathology Implementation Strategies in Sub Saharan Africa
Impact of Pathology Implementation Strategies in Sub Saharan Africa June 2015 ascp.org PATHOLOGY IN AFRICA Large abdominal wall mass What do you do?? Large lesion non-diagnostic? Have to do additional
More informationCancer Awareness Talk ICPAK 2014
Cancer Awareness Talk ICPAK 2014 F. Chite Asirwa, MB ChB. MD. MSc. Internist. Medical Oncologist & Hematologist Asst. Professor of Medicine Division of Hematology/Oncology Indiana University Email: fasirwa@iu.edu
More informationCancer Key facts The problem Cancer causes
Cancer Key facts Cancer is a leading cause of death worldwide, accounting for 7.6 million deaths (around 13% of all deaths) in 2008 (1). Lung, stomach, liver, colon and breast cancer cause the most cancer
More informationLeslie E. Lehmann, MD The Case for Support: Addressing the Needs of Cancer Patients Worldwide in the WHO Model Essential Medicines List
Leslie E. Lehmann, MD The Case for Support: Addressing the Needs of Cancer Patients Worldwide in the WHO Model Essential Medicines List Cancer Community Proposals Proposal Trastuzumab Proposal Imatinib
More informationAn introduction to the Essential Medicines concept: balancing innovation with public health priorities
An introduction to the Essential Medicines concept: balancing innovation with public health priorities World Oncology Forum Lugano 20 October 2017 Nicola Magrini Secretary, WHO Expert Committee on the
More informationSUSTAINING ACCESS TO HIGH QUALITY RADIOTHERAPY CARE: A LMIC PERSPECTIVE
SUSTAINING ACCESS TO HIGH QUALITY RADIOTHERAPY CARE: A LMIC PERSPECTIVE Dr Kennedy Lishimpi BSc MB ChB M.Med FC Rad Onc (SA) Director Cancer Control Ministry of Health Zambia ICARO2 21/06/17 Introduction
More informationPRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
More informationPerson-Centred Perspective Indicators in Canada:
Person-Centred Perspective Indicators in Canada: A REFERENCE REPORT Adolescents and Young Adults with Cancer Adolescents and Young Adults with Cancer Section 1. Adolescent and Young Adult Cancer by the
More informationMacmillan Publications
S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer
More informationAmerican Society of Clinical Oncology PATIENT EDUCATION MATERIALS CATALOG.
American Society of Clinical Oncology PATIENT EDUCATION MATERIALS CATALOG www.cancer.net www.cancer.net Tell your patients about the ASCO doctor-approved PATIENT INFORMATION WEBSITE Cancer.Net brings the
More informationMidland Region All Boards Development Days. Midland Cancer Network. 15, 16 October, 2015
Midland Region All Boards Development Days Midland Cancer Network 15, 16 October, 2015 NZ cancer incidence 1948-2011 Source: NZ Cancer 0.0 50.0 100.0 150.0 200.0 250.0 300.0 350.0 400.0 0 5000 10000 15000
More informationAnnual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
More informationIdentifying and counting people living with treatable but not curable cancer
Identifying and counting people living with treatable but not curable cancer Rachel White Joanna Pethick, Archie Macnair, Gregory Fallica, Jennifer Than and Jane Maher September 2018 Who are the people
More informationWelcome & Introductions. Questions to Ask to. Treatment Decisions
Make Informed Treatment Decisions Welcome & Introductions Make Informed Treatment Decisions Gail J. Roboz, MD Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell
More informationGlobal Strategies to Improve Cancer Care and Control
Women s Empowerment Cancer Advocacy Network (WE CAN) Conference Global Strategies to Improve Cancer Care and Control Tbilisi, Georgia October 15-16, 2013 Julie R. Gralow, M.D. Jill Bennett Endowed Professor
More informationThe number of new cases is expected to rise by about 70% over the next 2 decades.
World Health Organization Cancer Fact sheet February 2017 Key facts Cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012 1. The number
More informationThe Diagonal Approach to Health System Strengthening: A Roadmap for Expanding Access in LMICs August 28th, World Cancer Congress, Montreal
The Diagonal Approach to Health System Strengthening: A Roadmap for Expanding Access in LMICs August 28th, 2012 World Cancer Congress, Montreal Felicia Marie Knaul, PhD Harvard Global Equity Initiative,
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationCARIBBEAN CANCER NETWORK THE BELIZE CANCER SOCIETY S PERSPECTIVE CERVICAL CANCER ADVOCACY WORKSHOP ST. MAARTEN MARCH 22, 2013.
CARIBBEAN CANCER NETWORK THE BELIZE CANCER SOCIETY S PERSPECTIVE CERVICAL CANCER ADVOCACY WORKSHOP ST. MAARTEN MARCH 22, 2013. Laura Tucker-Longsworth MSN. RN. President The Belize Cancer Society BELIZE
More informationCancer Prevention & Control in Adolescent & Young Adult Survivors
+ Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview
More informationCANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients
CANCER MEDICINES IN DEVELOPMENT 2018 REPORT JUST THE FACTS MORE THAN 1.7 M ESTIMATED NEW CASES OF CANCER IN 2018 IN THE UNITED STATES MORE THAN 609,000 U.S. CANCER DEATHS ARE EXPECTED IN 2018 SINCE PEAKING
More informationCancer prevention and control
92 FIFTY-EIGHTH WORLD HEALTH ASSEMBLY Extracted from World Health Assembly 58 (2005) Official Records WHA58.22 Cancer prevention and control The Fifty-eighth World Health Assembly, Having examined the
More informationDisease Control Priorities, 3 rd Edition CANCER
www.dcp-3.org info@dcp-3.org Disease Control Priorities, 3 rd Edition CANCER Volume 3: Cancer Editors: Hellen Gelband Prabhat Jha Rengaswamy Sankaranarayanan Susan Horton Publication: November 2015 2 Disease
More informationAmerican Cancer Society Research Programs
American Cancer Society Research Programs The American Cancer Society dedicates more money to cancer research than any other private, not-for-profit, non-government funder of cancer research in the United
More informationThe medical team consists of 2 Hemato-Oncologists pediatrician and 6 Hematologists pediatricians.
Dr. Robert Reid Cabral Children s Hospital Dominican Republic Brief Description of the Hematology-Oncology Service Palliative Care Pilot Program and Metronomic Therapy Dr. Robert Reid Cabral Children's
More information2008 Oncology Pharmacy Preparatory Review Course Learning Objectives
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,
More information6 December 2012 Last updated at 01:15 GMT. Cancer's global toll
6 December 2012 Last updated at 01:15 GMT Cancer's global toll How a simple infection can trigger cancer By Joanne Silberner PRI's The World A girl in Uganda with Burkitt's lymphoma, caused by a virus
More informationPutting evidence into practice: Dissemination and implementation of an evidencebased cervical cancer prevention project in Ethiopia
Putting evidence into practice: Dissemination and implementation of an evidencebased cervical cancer prevention project in Ethiopia Jennifer Kue, PhD Assistant Professor College of Nursing OBJECTIVES Describe
More informationCancer. Chapter 31 Lesson 2
Cancer Chapter 31 Lesson 2 Tumors All cancers are tumors- masses of tissue. Not all tumors are cancers. Some tumors are benign- noncancerous. These tumors are surrounded by membranes that prevent them
More informationBLOOD AND LYMPH CANCERS
BLOOD AND LYMPH CANCERS 2 Blood and Lymph Cancers Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by Kenneth C. Anderson, MD Harvard Medical School and Dana-Farber
More informationCancer in Halton. Halton Region Cancer Incidence and Mortality Report
Cancer in Halton Halton Region Cancer Incidence and Mortality Report 2008 2012 The Regional Municipality of Halton March 2017 Reference: Halton Region Health Department, Cancer in Halton: Halton Region
More informationCompetent Pain Management for Older Patients With Cancer
Session length: 2 hours, 53 minutes Contact hours: 3.5 Pharmacology hours offered: 30 minutes 2005 ONS Virtual Institutes of Learning Evaluation Form Competent Pain Management for Older Patients With Cancer
More informationCommon Questions about Cancer
6 What is cancer? Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. The cancer cells form tumors that destroy normal tissue. If cancer cells break away from
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationCancer Causes Preventions Treatments Presentation By Dr. Bhavani Nair. MBBS;DGO;FRCP(C) Retired Radiation Oncologist University of Ottawa
Cancer Causes Preventions Treatments Presentation By Dr. Bhavani Nair. MBBS;DGO;FRCP(C) Retired Radiation Oncologist University of Ottawa In Ontario, someone is diagnosed with cancer every eight minutes
More informationBY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,
More informationPatient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia
Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia Thomas W. LeBlanc, MD, MA, MHS, FAAHPM Associate Professor of Medicine Division
More informationThe facts that disprove the four myths that undermine efforts to narrow the cancer divide by increasing access to CCC in LMICs:
Overview Low and middle income countries (LMICs) share a common, emerging, and largely unrecognized challenge: the burden of increasingly prevalent chronic and non-communicable diseases. This emerging
More informationOregon Health Plan Guideline Note 12
Oregon Health Plan Guideline Note 12 How do we implement cost effective cancer treatment in patients with short life expectancy with a limited budget? November 16, 2013 Kevin Olson MD History of Medicaid
More informationDate: Wednesday, 26 October :00PM. Location: Museum of London
The Treatment of Cancer Transcript Date: Wednesday, 26 October 2016-6:00PM Location: Museum of London 26 October 2016 The Treatment of Cancer Professor Christopher Whitty Being told you have cancer conjures
More informationSAMPLE. Survivorship Care Plan for Lymphoma (Diffuse Large B-Cell) General Information. Care team
SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,
More informationCancer research investment should shift from late stage treatment to early stage detection No!
Cancer research investment should shift from late stage treatment to early stage detection No! KC Soo National Cancer Centre Singapore Duke-NUS Graduate Medical School 3 caveats 1. The primacy of cancer
More informationMeeting the Challenge of Cancer Care in Northern Tanzania A Program for Comprehensive and Sustainable Care THE FOUNDATION FOR CANCER CARE IN TANZANIA
MEETING THE CHALLENGE OF CANCER CARE IN NORTHERN TANZANIA Meeting the Challenge of Cancer Care in Northern Tanzania A Program for Comprehensive and Sustainable Care THE FOUNDATION FOR CANCER CARE IN TANZANIA
More informationTrends in Oncology Care. Challenges and Obstacles. Lawrence N. Shulman, MD Dana-Farber Cancer Institute Brigham and Women s Hospital
Trends in Oncology Care Challenges and Obstacles Lawrence N. Shulman, MD Dana-Farber Cancer Institute Brigham and Women s Hospital Navigation Through The Continuum of Cancer Care Education Screening Early
More informationHealthy girls, healthy women
Healthy girls, healthy women Figures & Facts 1 The GAVI Alliance mission: Saving children s lives and protecting people s health by increasing access to immunisation in poor countries. GAVI/2011/Doune
More informationOverview CANCER. Cost Facts
Overview Cancer is a collection of diseases that result from abnormal and uncontrolled growth of cells. Everyone is susceptible to cancer and it can occur in any part of the body. Cancer is the second
More informationViruses and cancer: Should we be more afraid?
Viruses and cancer: Should we be more afraid? Viruses and cancer: Should we be more afraid? During the past 30 years it has become exceedingly clear that several viruses play significant roles in the development
More informationOPIOID RISK ASSESSMENT IN CANCER PATIENTS. Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management
OPIOID RISK ASSESSMENT IN CANCER PATIENTS Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management Walking the Tightrope of Pain Management Adverse Events Misuse Suicide Death
More informationBlood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen
Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells
More informationManaging Older Patients With Lymphoma and Multiple Myeloma
2006 ONS Congress Webcast Evaluation Form Managing Older Patients With Lymphoma and Multiple Myeloma Session length: 1 hour, 45 minutes Contact hours: 1.5 Pharmacology hours offered: 15 minutes How to
More informationChallenges and Opportunities in Prevention, Control and Early Detection of Cancer in Low Resource Settings
Challenges and Opportunities in Prevention, Control and Early Detection of Cancer in Low Resource Settings INSTITUTE OF MEDICINE S N ATIONAL C A N C ER POLICY FORUM BY D OYIN OLUWOLE, MD, MRCP, FRCP, FWA
More informationOVAC FY 2017 Appropriations Requests
OVAC FY 2017 Appropriations Requests One Voice Against Cancer (OVAC), a broad coalition of cancer-related organizations representing millions of Americans, supports the goals of the Cancer Moonshot initiative
More informationPRIORITIES FOR CANCER PREVENTION AND CONTROL IN ZIMBABWE
PRIORITIES FOR CANCER PREVENTION AND CONTROL IN ZIMBABWE ANNA MARY NYAKABAU, PARIRENYATWA HOSPITAL, ZIMBABWE Zimbabwe is among the top 22 countries in the world in terms of the burden of HIV. 1 Many of
More information2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North
More informationSurveillance after Treatment of Malignancies. John M. Burke, M.D. March 2013
Surveillance after Treatment of Malignancies John M. Burke, M.D. March 2013 Disclosures Advisory Boards Spectrum Alexion Genomic Health Dendreon Seattle Genetics Learning Objectives Improve ability to
More informationFACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
More informationCancer Cases Treated and Results
Cancer Cases Treated and Results Below are some of the cases, from more than 30 cases we have treated so far with good results. When reading the PET/CT scans, the picture on the left is before treatment,
More informationTargeted Medicine and Molecular Therapeutics. Angus McIntyre, M.D. Medical Oncologist, Addison Gilbert Hospital and Beverly Hospital October 6, 2009
Targeted Medicine and Molecular Therapeutics Angus McIntyre, M.D. Medical Oncologist, Addison Gilbert Hospital and Beverly Hospital October 6, 2009 Approaches to Cancer Prevention Screening and early diagnosis
More informationCancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC 20037 October 19-21, 2016 Wednesday, October 19, 2016 7:30 8:30 AM Registration
More informationProposing Trastuzumab as an Essential Medicine to Treat Cancer: Insight on Methodologies, Processes and Outcomes. Lorenzo Moja
Proposing Trastuzumab as an Essential Medicine to Treat Cancer: Insight on Methodologies, Processes and Outcomes Lorenzo Moja Essential Medicines List Secretariat Essential Medicines and Health Products
More informationCANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE
1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations
More informationBalancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer
2006 ONS Congress Webcast Evaluation Form Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer Session length: 1 hour, 49 minutes Contact hours: 1.6 Pharmacology hours offered:
More informationAn Overview. Paediatric Oncology. In Malawi
An Overview of Paediatric Oncology In Malawi 15.6 % of all cancers are attributable to infections 21% -100,000/yr in Africa; 9% - 375,000/yr in West Pidani et al 1990 IN AFRICA EARLY ACQUISITION OF VIRUSES
More informationHEALTHCARE CLAIMS TRACKER A FOCUS ON ONCOLOGY CLAIMS. September 2018 For the period January 2017 December 2017
HEALTHCARE A FOCUS ON CLAIMS September 208 For the period January 207 December 207 INTRODUCTION Cancer is one of the leading causes of death both globally and in South Africa. Worldwide, one in seven deaths
More informationCANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs
CANCER PREVENTION AND ACCESS TO MEDICINES Gracemarie Bricalli ESMO Head of International Affairs ESMO s 2020 Vision: Access to cancer care ESMO s 2020 vision statement recognises that progress in the management
More informationCSQI BACKGROUNDER What is The Cancer Quality Council of Ontario (CQCO)? What does CQCO do? What is the Cancer System Quality Index?
CSQI BACKGROUNDER What is The Cancer Quality Council of Ontario (CQCO)? Established in 2002 by the Ministry of Health and Long-Term Care (MOHLTC), the Cancer Quality Council of Ontario (CQCO) is an arm
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationWHAT ARE PAEDIATRIC CANCERS
WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600
More informationH&HD ANTINEOPLASTIC DRUG CARD ASSEMBLY INSTRUCTIONS
H&HD ANTINEOPLASTIC DRUG CARD ASSEMBLY INSTRUCTIONS Each of you should have 37 new cards: 7 orange cards for antimetabolites 11 white cards for miscellaneous drugs (2 DNA synthesis inhibitors, 1 enzyme,
More informationNew Developments in Cancer Treatment. Ian Rabinowitz MD
New Developments in Cancer Treatment Ian Rabinowitz MD Treatment Outline Angiogenesis inhibition Targeted therapy Immunotherapy Personalization of therapy Genomics and cancer Stem cells and cancer Angiogenesis
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationCLIC Sargent Eligibility Criteria
1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd
More informationONTARIO CANCER PLAN
ONTARIO CANCER PLAN 2011-2015 I want to live... I m still young, many people in my family have lived to be 100. I want to be around to watch my grandchildren grow up. Screening saved my life, I tell everybody
More informationCareers in Pediatric Hematology/Oncology
Careers in Pediatric Hematology/Oncology Prepared by The American Society of Pediatric Hematology/Oncology ASPHO 8735 W. Higgins Rd., Suite 300, Chicago, IL 60631 847.375.4716 aspho.org ABOUT ASPHO The
More informationTREATMENT COSTS OF PEDIATRIC CANCER IN RWANDA. Claire C. Neal
TREATMENT COSTS OF PEDIATRIC CANCER IN RWANDA Claire C. Neal A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the
More informationFibre and whole grains 'reduce bowel cancer risk'
11 November 2011 Last updated at 01:21 GMT Fibre and whole grains 'reduce bowel cancer risk' High fibre cereals are just one type of fibre which were shown to help prevent colorectal cancer Eating more
More informationCancer prevalence. Chapter 7
Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.
More informationASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer
ASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer Joseph Jacobson, MD Chair, QOPI Steering Committee Salem MA October 6, 2009 American Society of Clinical
More informationDEPARTMENT OF MEDICAL ONCOLOGY
DEPARTMENT OF MEDICAL ONCOLOGY DEPARTMENT OF MEDICAL ONCOLOGY About Narayana Health City One of the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary
More informationIntroduction to Medical Oncology and Clinical Trials
Introduction to Medical Oncology and Clinical Trials Elizabeth Griffiths, MD Assistant Professor of Medicine Leukemia Section Roswell Park Cancer Institute elizabeth.griffiths@roswellpark.org Outline Burden
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationOVERVIEW OF PAEDIATRIC SURGICAL ONCOLOGY SERVICES IN KENYA
OVERVIEW OF PAEDIATRIC SURGICAL ONCOLOGY SERVICES IN KENYA PROF. ROBERT TENGE KUREMU Paediatric Surgeon, Moi University School of Medicine KENYA PAEDIATRIC ASSOCIATION ANNUAL SCIENTIFIC CONFERENCE ELDORET
More informationIntroduction to Medical Oncology and Clinical Trials. Outline. Definition and Burden of Disease 3/28/2017. Burden of Disease
Introduction to Medical Oncology and Clinical Trials Elizabeth Griffiths, MD Assistant Professor of Medicine Leukemia Section Roswell Park Cancer Institute elizabeth.griffiths@roswellpark.org Burden of
More informationHigh Impact Cancer Research Program
High Impact Cancer Research Program Advanced training in methods and conduct of clinical research APPLY AT HMS.HARVARD.EDU/HICR Dear Colleagues: Challenging problems. New strategies for success. Cross-disciplinary
More informationAmerican Society of Clinical Oncology PATIENT EDUCATION MATERIALS CATALOG.
American Society of Clinical Oncology PATIENT EDUCATION MATERIALS CATALOG www.cancer.net www.cancer.net Tell your patients about the doctor-approved PATIENT INFORMATION WEBSITE FROM ASCO Cancer.Net brings
More informationAhmedin Jemal, DVM, PhD American Cancer Society
The 2 nd Edition of The Cancer Atlas Cancer Interventions and Potential for Impact Ahmedin Jemal, DVM, PhD American Cancer Society Session code: CTS.4.230 www.worldcancercongress.org Interventions Across
More informationSHEDDING A LITTLE LIGHT ON THE BIGGER PROBLEM
NationalPCF.org SHEDDING A LITTLE LIGHT ON THE BIGGER PROBLEM 1.7 MILLION NEW CANCER CASES EVERY YEAR 600,000 PEOPLE WILL DIE More than of those who survive childhood cancer will have a significant health
More informationChapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia
Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia Introduction Cancer is a major concern in FA patients. This chapter will describe the most common types of non-head and neck solid
More informationHematologic Malignancies 2013 Retrospective Study at Truman Medical Center
Hematologic Malignancies 2013 Retrospective Study at Truman Medical Center Kristen Strasser, MD & Abdulraheem Qasem, MD Introduction: Hematologic Malignancies includes malignant diseases of the bone marrow
More informationProject ECHO: Extension for Community Healthcare Outcomes
Project ECHO: Extension for Community Healthcare Outcomes Kathleen Schmeler, MD Department of Gynecologic Oncology Ellen Baker, MD, MPH Melissa Lopez, MS Cancer Prevention and Control Platform No Financial
More informationCancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/32 Provisional agenda item 15.6 13 April 2017 Cancer prevention and control in the context of an integrated approach Report by the Secretariat 1. In January 2017, the
More informationHow Italy and France take on rare sarcoma cancers
Page 4 of 12 Road safety road transport Trucks and CO2 1. Home 2. News 3. Health 4. How Italy and France take on rare sarcoma cancers How Italy and France take on rare sarcoma cancers By Hannah Black and
More informationSKCC Protocol Review Committee New Study Application
Instructions: Submit the following documents to prc@jefferson.edu - Completed New Study Application (aka MCSF) - Protocol - Protocol Facilitation Committee Approval (if applicable) - MDG Priority Score
More informationWorld Cancer Congress, August 2012, Montreal, Canada
World Cancer Congress, August 2012, Montreal, Canada Palliative Care and Health Systems Strengthening in Africa Fatia Kiyange Director of Programs African Palliative Care Association Kampala, Uganda The
More informationClinical Policy: Levoleucovorin (Fusilev) Reference Number: ERX.SPA.181 Effective Date:
Clinical Policy: (Fusilev) Reference Number: ERX.SPA.181 Effective Date: 01.11.17 Last Review Date: 11.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationRadiation Therapy in Africa
Radiation Therapy in Africa Surbhi Grover, MD MPH Senior Lecturer, School of Medicine, University of Botswana Oncology Consultant, Princess Marina Hospital, Botswana Assistant Professor, Dept of Radiation
More informationBRINGING ONCOLOGY SPECIALTY CARE TO THE COMMUNITY USING NURSING NAVIGATION
BRINGING ONCOLOGY SPECIALTY CARE TO THE COMMUNITY USING NURSING NAVIGATION Christopher S. Lathan, M.D., M.S., M.P.H. Assistant Professor of Medicine Faculty Director of Cancer Care Equity, Dana-Farber
More informationPrecision Medicine. What does it mean? What s not to like? What were we doing before? How successful?
Precision Medicine What does it mean? What s not to like? What were we doing before? How successful? Dr Stephen Vaughan Director, Cancer Services Institute Epworth HealthCare Epworth HealthCare 1 Issues
More informationCFM Grand Rounds Continuing Education
CFM Grand Rounds Continuing Education In order to receive credit for participating today, please text the code ROSZAM to 919.213.8033. Must be entered into system within 12 hours of session. This session
More information